The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

被引:1359
作者
Ibrahim, EH
Sherman, G
Ward, S
Fraser, VJ
Kollef, MH
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
[3] Barnes Jewish Hosp, Dept Nursing, St Louis, MO 63110 USA
关键词
antibiotics; bacteremia; bloodstream infections; Candida species; enterococci; intensive care; outcomes; resistance; Staphylococcus aureus;
D O I
10.1378/chest.118.1.146
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To evaluate the relationship between the adequacy of antimicrobial treatment for bloodstream infections and clinical outcomes among patients requiring ICU admission. Design: Prospective cohort study. Setting: A medical ICU (19 beds) and a surgical ICU (18 beds) from a university-affiliated urban teaching hospital. Patients: Between July 1997 and July 1999, 492 patients were prospectively evaluated. Intervention: Prospective patient surveillance and data collection. Results: One hundred forty-seven patients (29.9%) received inadequate antimicrobial treatment for their bloodstream infections. The hospital mortality rate of patients with a bloodstream infection receiving inadequate antimicrobial treatment (61.9%) was statistically greater than the hospital mortality rate of patients with a bloodstream infection who received adequate antimicrobial treatment (28.4%; relative risk, 2.18; 95% confidence interval [CI], 1.77 to 2.69; p < 0.001). Multiple logistic regression analysis identified the administration of inadequate antimicrobial treatment as an independent determinant of hospital mortality (adjusted odds ratio [AOR], 6.86; 95% CI, 5.09 to 9.24; p < 0.001). The most commonly identified bloodstream pathogens and their associated rates of inadequate antimicrobial treatment included vancomycin-resistant enterococci (n = 17; 100%), Candida species (n = 41; 95.1%), oxacillin-resistant Staphylococcus aureus (n = 46; 32.6%), coagulase-negative staphylococci (n = 96; 21.9%), and Pseudomonas aeruginosa (n = 22; 10.0%). A statistically significant relationship, was found between the rates of inadequate antimicrobial treatment for individual microorganisms and their associated rates of hospital mortality (Spearman correlation coefficient = 0.8287; p = 0.006), Multiple logistic regression analysis also demonstrated that a bloodstream infection attributed to Candida species (AOR, 51.86; 95% CI, 24.57 to 109.49; p < 0.001), prior administration. of antibiotics during the same hospitalization (AOR, 2.08; 95% CI, 1.58 to 2.74; p = 0.008), decreasing serum albumin concentrations (1-g/dL decrements) (AOR, 1.37; 95% CI, 1.21 to 1.56; p = 0.014), and increasing central catheter duration (I-day increments) (AOR, 1.03; 95% CI, 1.02 to 1.04; p = 0.008) were independently associated with the administration of inadequate antimicrobial treatment. Conclusions: The administration of inadequate antimicrobial treatment to critically ill patients with bloodstream infections is associated with a greater hospital mortality compared with adequate antimicrobial treatment of bloodstream infections. These data suggest that clinical efforts should be aimed at reducing the administration of inadequate antimicrobial treatment to hospitalized patients with bloodstream infections, especially individuals infected with antibiotic-resistant bacteria and Candida species.
引用
收藏
页码:146 / 155
页数:10
相关论文
共 48 条
  • [1] Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
    AlvarezLerma, F
    Pellus, AM
    Sanchez, BA
    Ortiz, EP
    Jorda, R
    Barcenilla, F
    Maravi, E
    Galvan, B
    Palomar, M
    Serra, J
    Bermejo, B
    Mateu, A
    Quintana, E
    Palacios, MS
    Giral, R
    Gonzalez, V
    Lerma, FA
    Mesa, JL
    Melgarejo, JA
    Martinez, J
    Insausti, J
    Olaechea, P
    Chanovas, M
    Gilabert, A
    Junquera, C
    Valles, J
    Palacios, F
    Calvo, R
    Mesalles, E
    Nava, J
    Santos, A
    Armengol, S
    Marzo, D
    [J]. INTENSIVE CARE MEDICINE, 1996, 22 (05) : 387 - 394
  • [2] [Anonymous], CHEST
  • [3] ASCAR JF, 1997, CLIN INFECT DIS, V24, pS17
  • [4] Antibiotic resistance: A view from the pharmaceutical industry
    Bax, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 : S151 - S153
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] BRYAN CS, 1983, REV INFECT DIS, V5, P629
  • [7] Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin
    Caballero-Granado, FJ
    Cisneros, JM
    Luque, R
    Torres-Tortosa, M
    Gamboa, F
    Díez, F
    Villanueva, JL
    Pérez-Cano, R
    Pasquau, J
    Merino, D
    Menchero, A
    Mora, D
    López-Ruz, MA
    Vergara, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) : 520 - 525
  • [8] Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
    Carmeli, Y
    Troillet, N
    Karchmer, AW
    Samore, MH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) : 1127 - 1132
  • [9] ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY
    CHOW, JW
    FINE, MJ
    SHLAES, DM
    QUINN, JP
    HOOPER, DC
    JOHNSON, MP
    RAMPHAL, R
    WAGENER, MM
    MIYASHIRO, DK
    YU, VL
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 585 - 590
  • [10] EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA
    COHEN, ML
    [J]. SCIENCE, 1992, 257 (5073) : 1050 - 1055